Skip to content
Nonprofiteer
← PEDIATRIC CANCER RESEARCH FOUNDATION

Form 990 for tax year 2023

Filed by PEDIATRIC CANCER RESEARCH FOUNDATION.

Totals

Total revenue
$3,984,492
Total expenses
$3,727,170
Contributions and grants received
$4,074,348
Grants paid
$2,040,951
Program service revenue
$0
Investment income
$49,338
Other revenue
-$139,194
Total assets, end of year
$3,305,936
Total liabilities, end of year
$1,575,973
Net assets or fund balances, end of year
$1,729,963
Program services expenses (Part IX)
$2,638,079
Management and general expenses
$153,239
Fundraising expenses
$935,852
Program service expenses (Part III)
$2,638,079

Program services were 70.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $1,764,148

  • 1e · Government grants (contributions)

    $161,825

  • 1f · All other contributions, gifts and grants

    $2,148,375

  • 1g · Noncash contributions included above

    $177,326

  • 3 · Investment income

    total $25,508 · excluded $25,508

  • 7a · Gross sales of assets other than inventory

    securities $1,525,762

  • 7b · Less cost or other basis and sales expenses

    securities $1,501,932

  • 7c · Gain or loss

    securities $23,830

  • 7d · Net gain or loss

    total $23,830 · excluded $23,830

  • 8a · Fundraising events: gross income

    $1,405,198

  • 8a · Fundraising events: contributions included on line 1c

    $1,764,148

  • 8b · Fundraising events: direct expenses

    $1,544,392

  • 8c · Net income from fundraising events

    total -$139,194 · excluded -$139,194

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $1,953,951 · program services $1,953,951

  • 2 · Grants to domestic individuals

    total $87,000 · program services $87,000

  • 5 · Compensation of officers, directors and key employees

    total $240,888 · program services $75,170 · management and general $25,338 · fundraising $140,380

  • 7 · Other salaries and wages

    total $474,256 · program services $147,994 · management and general $49,885 · fundraising $276,377

  • 9 · Other employee benefits

    total $13,536 · program services $4,224 · management and general $1,424 · fundraising $7,888

  • 10 · Payroll taxes

    total $48,970 · program services $15,281 · management and general $5,151 · fundraising $28,538

  • 11b · Fees: legal

    total $9,121 · program services $871 · management and general $300 · fundraising $7,950

  • 11c · Fees: accounting

    total $74,270 · program services $24,252 · management and general $8,351 · fundraising $41,667

  • 11g · Fees: other

    total $288,333 · program services $96,164 · management and general $33,098 · fundraising $159,071

  • 12 · Advertising and promotion

    total $208,498 · program services $54,044 · fundraising $154,454

  • 14 · Information technology

    total $14,170 · program services $4,627 · management and general $1,593 · fundraising $7,950

  • 16 · Occupancy

    total $139,082 · program services $43,415 · management and general $14,612 · fundraising $81,055

  • 23 · Insurance

    total $12,239 · program services $2,159 · management and general $2,503 · fundraising $7,577

  • 24a · Other expenses: OTHER PROGRAM SERVICES

    total $119,237 · program services $119,237

  • 24b · Other expenses: POSTAGE, PRINTING, AND

    total $19,293 · program services $3,859 · management and general $5,787 · fundraising $9,647

  • 24c · Other expenses: MISCELLANEOUS

    total $18,033 · program services $5,831 · management and general $4,371 · fundraising $7,831

  • 24d · Other expenses: CREDIT CARD FEES

    total $6,293 · management and general $826 · fundraising $5,467

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,126,434 · end of year $933,546

  • 2 · Savings and temporary cash investments

    beginning of year $222,357 · end of year $594,253

  • 3 · Pledges and grants receivable

    beginning of year $153,450 · end of year $0

  • 4 · Accounts receivable

    beginning of year $0 · end of year $121,345

  • 9 · Prepaid expenses and deferred charges

    beginning of year $181,147 · end of year $113,268

  • 10a · Land, buildings and equipment: cost or other basis

    $48,941

  • 10b · Land, buildings and equipment: accumulated depreciation

    $48,941

  • 10c · Land, buildings and equipment, net

    beginning of year $0 · end of year $0

  • 11 · Investments: publicly traded securities

    beginning of year $987,450 · end of year $999,710

  • 13 · Investments: program-related

    beginning of year $250,000 · end of year $250,000

  • 15 · Other assets

    beginning of year $360,367 · end of year $293,814

  • 17 · Accounts payable and accrued expenses

    beginning of year $183,556 · end of year $247,474

  • 18 · Grants payable

    beginning of year $1,068,726 · end of year $846,422

  • 19 · Deferred revenue

    beginning of year $186,355 · end of year $164,181

  • 25 · Other liabilities

    beginning of year $378,216 · end of year $317,896

  • 27 · Net assets without donor restrictions

    beginning of year $1,464,352 · end of year $1,729,963

Mission and programs · 2023

Mission

FUND RESEARCH TO POWER CURES THAT REDUCE THE PERCENTAGE OF CHILDREN WHO PERISH FROM CANCER UNTIL THAT NUMBER REACHES ZERO.

Activities or mission (Part I)

THE FOUNDATION'S MISSION IS TO IMPROVE THE CARE, QUALITY OF LIFE AND SURVIVAL RATE OF CHILDREN WITH MALIGNANT DISEASES. THE FOUNDATION RAISES FUNDS TO SUPPORT STATE-OF-THE-ART RESEARCH THAT WILL ULTIMATELY LEAD TO A CURE FOR ALL CHILDHOOD CANCERS.

  • PEDIATRIC CANCER RESEARCH ACTIVITIES - PRIMARY FUNDING SOURCE FOR RESEARCH STUDIES, STAFF & EQUIPMENT NEEDS FOR PEDIATRIC CANCER RESEARCH LABS. SEE SCHEDULE I FOR ADDITIONAL DETAIL.

    Expenses $2,638,079 · Grants $2,040,951

As filed on the 2023 return.

Listed in Part VII

  • Steve Giusto

    PRESIDENT

    Total calculated
    $0
    Hours/week
    1

  • John Weiner

    VICE-PRESIDENT

    Total calculated
    $0
    Hours/week
    1

  • Tom Brennan

    TREASURER

    Total calculated
    $0
    Hours/week
    1

  • Keith Koeller

    SECRETARY

    Total calculated
    $0
    Hours/week
    1

  • Beth Abrams

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Susie Buchan

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • John Coon

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Tim Cromwell

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Cherie Daly

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Scott Ecker

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Elizabeth McNulty

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Janet Mitchell

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Cameron Munson

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Amanda Saratsis

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Len Shulman

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • John Vallely

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Troy Varenchik

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Darth Vaughn

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Nicole Wilkins

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Jason O'Donnell

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Jeri Wilson

    EXECUTIVE DIRECTOR

    Total calculated
    $240,888
    From this org
    $221,538
    From related orgs
    $0
    Other
    $19,350
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $211,538
    Bonus
    $10,000
    Other
    $0
    Deferred
    $12,900
    Nontaxable benefits
    $6,450
    Filer's total
    $240,888

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Written employment contract
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

  • NEW YORK MEDICAL COLLEGE

    $550,000

    PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE

  • MEMORIAL SLOAN KETTERING

    $150,000

    TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS

  • UCSF

    $115,000

    TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA

  • STANFORD UNIVERSITY

    $115,000

    TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML

  • DANA FARBER

    $105,000

    PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA

  • MD ANDERSON

    $91,717

    COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY

  • CASE WESTERN

    $75,000

    USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS

  • BAYLOR COLLEGE OF MEDICINE

    $75,000

    OFF-THE-SHELF COMBINATION CANCER IMMUNOTHERAPY WITH ONCOLYTIC ADENO-IMMUNOTHERAPY AND CAR NK CELL THERAPY FOR PEDIATRIC SARCOMA

  • UNIVERSITY OF ALABAMA BIRMINGHAM

    $74,007

    INTRANASAL DELIVERY OF TARGETING NANOLIPOSOMAL THERAPEUTICS FOR PEDIATRIC GLIOMA

  • UCLA FOUNDATION

    $70,000

    RESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE OF AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER.

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • PEDIATRIC CANCER RESEARCH FOUNDATION NEW YORK A NOT FOR PROFIT CORPORATION

    501(C)(3) · FUNDING SOURCE FOR RESEARCH · NY

Provenance

Return type
form_990
Tax year
2023
Filed
24 September 2024
IRS schema version
2023v5.1
Source object
202402729349300305

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.